New pill shows promise against Hard-to-Treat cancers
Disease control
Not yet recruiting
This study tests an experimental drug called TYK-01054 for people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check if the drug can shrink tumors. About 219 adults will take part in this early-phase trial.
Phase: PHASE1, PHASE2 • Sponsor: TYK Medicines, Inc • Aim: Disease control
Last updated May 11, 2026 20:46 UTC